3186 results for «3538»

Filter By

3186 results

Comprehensive assessment of mitral valve disorders and treatment outcomes

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

This session offers a comprehensive exploration of mitral valve disorders, covering diagnosis and severity assessment from multiple perspectives. From morphology-based diagnosis to echocardiography and CMR assessments, gain insights into distinguishing between rheumatic and calcific mitral stenosis, evaluating outcomes post-TMVR and surgical repair, and assessing bioprosthetic and...

Comprehensive assessment of mitral valve disorders and treatment outcomes

Optimizing case selection and procedure guidance in transcatheter mitral valve interventions

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...

Optimizing case selection and procedure guidance in transcatheter mitral valve interventions

Tricuspid valve disease: diagnosis and classification

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

Discover, in this comprehensive 3rd episode of PCR Imaging Valves Madrid 2024, the nuances of diagnosing and grading tricuspid valve disease, including insights into normal and abnormal function post-repair or replacement, the pivotal role of imaging in valve quantification and device selection, strategies for assessing right ventricular...

Tricuspid valve disease: diagnosis and classification

Advanced imaging strategies in transcatheter tricuspid valve therapies

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

In this PCR Imaging Valves Madrid 2024 session, discover the use of various imaging techniques in transcatheter tricuspid valve therapies, ranging from standard TEE screening to comprehensive intra-procedural assessments, facilitating optimal device selection, procedural success, and post-procedural monitoring.

Advanced imaging strategies in transcatheter tricuspid valve therapies

Mastering techniques from basic to complex - Imaging for aortic stenosis

16 Feb 2024 – From PCR Tokyo Valves 2024

Learn to master different imaging techniques for aortic stenosis through these slides. Gain insight into the concomitance of aortic stenosis and coronary artery disease, and learn about the pitfalls of aortic stenosis diagnosis in this session.

The EVOQUE and PASCAL Precision systems in action: simulation- and case-based learning

20 Nov 2023 – From PCR London Valves 2023

This session explores the features of the PASCAL Precision and the EVOQUE tricuspid replacement systems through simulators and case presentations, while a panel of experts discuss the technology, witnessing live demonstrations of treating mitral and tricuspid regurgitation patients.

The EVOQUE and PASCAL

Valve performance and durability - Main considerations in selecting the right TAVI valve

20 Nov 2023 – From PCR London Valves 2023

In this session with LIVE case, participants discuss the critical role of valve selection in influencing patient outcomes. The focus includes understanding the latest clinical outcomes of supra-annular TAVI and SAVR, exploring their practical implications. The session also highlights the contribution of novel technology Evolut FX, in...

Valve performance and durability - Main considerations in selecting the right TAVI valve

TAVI and beyond: tackling coronary challenges

19 Nov 2023 – From PCR London Valves 2023

Consult this session to gain a comprehensive understanding of the crucial role of coronary access post-TAVI, and the impact of TAV design and implantation technique on coronary access. Gain some insights into the intricacies of coronary accessibility from extensive bench test work and the impact of TAV design in...

TAVI and beyond: tackling coronary challenges

Is only fixing functional mitral regurgitation in heart failure patients enough?

20 Nov 2023 – From PCR London Valves 2023

This session offers insights into combo therapy involving Carillon for patients with functional mitral regurgitation. It covers details of the EMPOWER trial, a double-blinded, sham-controlled study, and explores the potential benefits of early treatment for patients with functional mitral regurgitation.

Is only fixing functional mitral regurgitation in heart failure patients enough?

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

19 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to understand the challenges of imaging for aortic regurgitation and how it can lead to underdiagnosis. Discover the data from the ALIGN-AR trial studying TAVI in aortic regurgitation patients, and learn about the Trilogy valve and the future of TAVI...

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

Essentials of lifetime management of TAVI patients

20 Nov 2023 – From PCR London Valves 2023

In this session, discover the key features and benefits of next-generation transcatheter heart valve technology. Gain insights into managing bicuspid and valve-in-valve interventions, and understand the procedural and clinical significance of intermediate and XL sizes in addressing unmet clinical needs.

Essentials of lifetime management of TAVI patients

Expert roundtable: 4D ICE in tricuspid interventions

20 Nov 2023 – From PCR London Valves 2023

Join this session if you want to get familiar with the 4D ICE technology and the key elements of image guidance for tricuspid interventions, understand how 4D ICE can assist in specific procedural steps during challenging tricuspid interventions, and engage in an interactive discussion with experts...

Expert roundtable: 4D ICE in tricuspid interventions

Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system

20 Nov 2023 – From PCR London Valves 2023

Participate in this session to stay informed about the latest clinical and real-world evidence for mitral and tricuspid TEER using PASCAL. Explore case-based discussions on mitral regurgitation treatment using PASCAL Precision, and actively participate in an educational tricuspid TEER recorded case procedure featuring the PASCAL Precision.

Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system

TAVI unleashed: optimisation of immediate and long-term outcomes

20 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to gain insights into the effects of paravalvular leak, conduction disturbances, stroke, and permanent pacemaker issues following transcatheter aortic valve implantation. The discussion also delves into the design of transcatheter heart valves and its implications for selecting the initial valve...

TAVI unleashed: optimisation of immediate and long-term outcomes

Defying complexity: achieving optimal TAVI procedural outcomes in challenging anatomies with the new Evolut FX

20 Nov 2023 – From PCR London Valves 2023

Watch this session to understand factors to consider when deciding on valve selection, recognize the significance of device choice and implantation technique in redo-TAVI, and acquire insights into anticipating challenges associated with implanting a bicuspid valve, large anatomy, and a horizontal aorta.

Defying complexity: achieving optimal TAVI procedural outcomes in challenging anatomies with the new Evolut FX

Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...

19 Nov 2023 – From PCR London Valves 2023

Discover the mitral late-breaking trials which were presented during PCR London Valves 2023: 

  • One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
  • AltaValve transseptal programme update
  • Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
  • Combined impact of mitral valve gradients and mitral regurgitation reduction...
Mitral Late-Breaking Trials - PCR London Valves 2023

Essentials of lifetime management of TAVI patients

21 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...

Essentials of lifetime management of TAVI patients

VitaFlow - The electrically enable self-expanding TAVI valve

21 Nov 2023 – From PCR London Valves 2023

This session provides insights into the unique design and advantages of VitaFlow Liberty for TAVI. It covers techniques to minimize microdislodgement during the procedure, identifies situations and patient types most suitable for VitaFlow Liberty, and reviews early clinical results associated with this technology.

VitaFlow - The electrically enable self-expanding TAVI valve

Facing the challenges of resource shortages - An outlook into the future of TAVI?

21 Nov 2023 – From PCR London Valves 2023

Join this session to discover strategies for optimizing care quality and patient safety, especially in resource-constrained environments. Gain insights into variations in TAVI patient treatment across European countries, understanding the associated consequences. Engage in discussions exploring potential solutions to ensure long-term, high-quality patient care despite challenges...

Facing the challenges of resource shortages - An outlook into the future of TAVI?

The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...

19 Nov 2023 – From PCR London Valves 2023

Discover the top late-breaking trials which were presented during PCR London Valves 2023:

  • TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
  • Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
  • Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
  • Artificial intelligence derived risk...
PCR London Valves 2023 Top Late-Breaking Trials
Didn’t find what you were looking for?